This site is intended for health professionals only

Home / News / Pharmacists alerted after wrong patient information leaflet put into some osteoporosis medicine packs

Pharmacists alerted after wrong patient information leaflet put into some osteoporosis medicine packs


By Beth Kennedy
Editor-in-chief

04 Apr 2019

The Government’s medicines watchdog has called on pharmacists to rectify a problem with the patient information leaflet (PIL) in some packs of Zoledronic acid 5mg solution for infusion.

Some packs of the drug – used to treat bone diseases like osteoporosis – manufactured by Ranbaxy UK mistakenly contain the PIL for Temozolomide 180mg capsules instead of the correct one, the Medicines and Healthcare products Regulatory Agency (MHRA) warned today (4 April).

Pharmacists should check packs of the affected batch contains the right PIL and replace it with the correct one if they find packs that do not, the MHRA said. The correct PIL can be downloaded here.

The affected batch is:

Batch Number Expiry Date Pack Size First Distributed
JKT1576A 30/04/2020 1 x 100ml 12th October 2018

 

Those with any enquiries should contact the Ranbaxy/Sun Pharmaceuticals customer services team on 020 8848 5050 or email Cserv.uk@sunpharma.com


Want news like this straight to your inbox?


Latest News

Pharmacists should use consultations to assess self-harm, says draft NICE guidance
Community pharmacy teams should use consultations and medicines reviews as an 'opportunity to assess self-harm...
pfizer
Pharmacists can extend shelf life of Pfizer vaccines ‘near expiry’
Pharmacy-led vaccination sites can extend the shelf life of certain batches of the Pfizer Covid...
Boots consultation about terminal illness
Boots launches palliative care service to support terminally ill patients
Boots UK has launched a new palliative care service in its pharmacies to provide ‘accessible...